natgillin/translations-raw huggingface dataset:
It has appeared from the various examinations made that plant protection products containing triflumuron may be expected to satisfy, in general, the requirements laid down in Article 5(1)(a) and (b) of Directive 91/414/EEC, in particular with regard to the uses which were examined and detailed in the Commission review report.
Različne preiskave so pokazale, da se za fitofarmacevtska sredstva, ki vsebujejo triflumuron, lahko pričakuje, da na splošno izpolnjujejo zahteve iz člena 5(1)(a) in (b) Direktive 91/414/EGS, zlasti pri uporabah, ki so bile proučene in podrobno navedene v poročilu Komisije o pregledu.
It is therefore appropriate to include triflumuron in Annex I, in order to ensure that in all Member States the authorisations of plant protection products containing this active substance may be granted in accordance with the provisions of that Directive.
Zato je primerno vključiti triflumuron v Prilogo I, da se v vseh državah članicah v skladu z določbami navedene direktive lahko registrirajo fitofarmacevtska sredstva, ki vsebujejo to aktivno snov.
Without prejudice to that conclusion, it is appropriate to obtain confirmatory information on certain specific points.
Brez poseganja v navedeni sklep je primerno pridobiti dodatne informacije o nekaterih posameznih točkah.
Therefore, it is appropriate to require that the applicant submit confirmatory information as regards the long-term risk to birds, the risk to aquatic invertebrates and the risk to bee brood development.
Zato je primerno zahtevati, da vlagatelj predloži dodatne informacije o dolgoročnem tveganju za ptice ter tveganju za vodne nevretenčarje in razvoj čebelje zalege.
This Directive shall enter into force on 1 April 2011.
Ta direktiva začne veljati 1. aprila 2011.
OJ L 71, 17.3.2009, p. 59.
UL L 71, 17.3.2009, str. 59.
Available online: www.efsa.europa.eu/efsajournal.htm.
Na voljo na spletu: http://www.efsa.europa.eu/efsajournal.htm.
CAS No: 64628-44-0
Št. CAS: 64628-44-0
CIPAC No: 548
Št. CIPAC: 548
N,N’-bis-[4-(trifluoromethoxy)phenyl]urea: not more than 1 g/kg,
N,N’-bis-[4-(trifluoromethoxy)phenyl]urea: največ 1 g/kg
4-trifluoro-methoxyaniline: not more than 5 g/kg.
4-trifluoro-methoxyaniline: največ 5 g/kg
1 April 2011
1. april 2011
31 March 2021
31. marec 2021
For the implementation of the uniform principles of Annex VI the conclusions of the review report on triflumuron, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 28 January 2011, shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu triflumurona ter zlasti dodatka I in II h končni različici poročila, ki jo je Stalni odbor za prehranjevalno verigo in zdravje živali pripravil 28. januarja 2011.
the protection of the aquatic environment,
varovanje vodnega okolja,
the protection of honeybees.
zaščito medonosnih čebel.
Conditions of authorisation shall include risk mitigation measures, where appropriate.
Pogoji registracije morajo po potrebi vključevati ukrepe za zmanjšanje tveganja.
The Member States concerned shall ensure that the applicant submits to the Commission confirmatory information as regards the long-term risk to birds, the risk to aquatic invertebrates and the risk to bee brood development.
Zadevne države članice zagotovijo, da vlagatelj Komisiji predloži dodatne informacije o dolgoročnem tveganju za ptice ter tveganju za vodne nevretenčarje in razvoj čebelje zalege.
The Member States concerned shall ensure that the applicant submits such information to the Commission by 31 March 2013.’
Zadevne države članice zagotovijo, da vlagatelj te informacije Komisiji predloži do 31. marca 2013.“
Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 30 September 2011 at the latest.
Države članice sprejmejo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje do 30. septembra 2011.
European Food Safety Authority: Conclusion on the peer review of the pesticide risk assessment of the active substance triflumuron; EFSA Journal 2011; 9(1):1941. [81 pp.]. doi:10.2903/j.efsa.2010.1941.
[6] Evropska agencija za varnost hrane: Sklep o strokovnem pregledu ocene tveganja pesticidov z aktivno snovjo triflumuron, EFSA Journal 2011; 9(1):1941, (str. 81). doi:10.2903/j.efsa.2010.1941.
Directive 2011/24/EU of the European Parliament and of the Council
Direktiva 2011/24/EU Evropskega parlamenta in Sveta
on the application of patients’ rights in cross-border healthcare
o uveljavljanju pravic pacientov pri čezmejnem zdravstvenem varstvu
Having regard to the Treaty on the Functioning of the European Union, and in particular Articles 114 and 168 thereof,
ob upoštevanju Pogodbe o delovanju Evropske unije in zlasti členov 114 in 168 Pogodbe,
According to Article 168(1) of the Treaty on the Functioning of the European Union (TFEU), a high level of human health protection is to be ensured in the definition and implementation of all Union policies and activities.
V skladu s členom 168(1) Pogodbe o delovanju Evropske unije (PDEU) je treba pri opredeljevanju in izvajanju vseh politik in dejavnosti Unije zagotoviti visoko raven varovanja zdravja ljudi.
This implies that a high level of human health protection is to be ensured also when the Union adopts acts under other Treaty provisions.
To pomeni, da je treba visoko raven varovanja zdravja ljudi zagotoviti tudi, kadar Unija sprejme akte v skladu z drugimi določbami Pogodbe.
Article 114 TFEU is the appropriate legal basis since the majority of the provisions of this Directive aim to improve the functioning of the internal market and the free movement of goods, persons and services.
Člen 114 PDEU je ustrezna pravna podlaga, saj je namen večine določb te direktive izboljšati delovanje notranjega trga ter prostega pretoka blaga, oseb in storitev.
Given that the conditions for recourse to Article 114 TFEU as a legal basis are fulfilled, Union legislation has to rely on this legal basis even when public health protection is a decisive factor in the choices made.
Glede na to, da so pogoji za uporabo člena 114 PDEU kot pravne podlage izpolnjeni, se mora zakonodaja Unije na to pravno podlago opirati tudi, kadar je varovanje javnega zdravja odločilni dejavnik pri sprejetih odločitvah.
In this respect, Article 114(3) TFEU explicitly requires that, in achieving harmonisation, a high level of protection of human health is to be guaranteed taking account in particular of any new development based on scientific facts.
V tej zvezi člen 114(3) PDEU izrecno zahteva, da je treba v prizadevanjih za usklajenost zagotoviti visoko raven varovanja zdravja ljudi, pri tem pa zlasti upoštevati vsa nova dognanja na podlagi znanstvenih dejstev.
The health systems in the Union are a central component of the Union’s high levels of social protection, and contribute to social cohesion and social justice as well as to sustainable development.
Zdravstveni sistemi v Uniji so osrednji nosilec visokih ravni socialne zaščite v Uniji ter prispevajo k socialni koheziji in socialni pravičnosti, kakor tudi k trajnostnemu razvoju.
They are also part of the wider framework of services of general interest.
Prav tako so del širšega okvira storitev splošnega pomena.
Notwithstanding the possibility for patients to receive cross-border healthcare under this Directive, Member States retain responsibility for providing safe, high quality, efficient and quantitatively adequate healthcare to citizens on their territory.
Ne glede na to, da obstaja možnost, da so pacienti deležni čezmejnega zdravstvenega varstva v skladu s to direktivo, države članice same ohranijo odgovornost za zagotavljanje varnega, visokokakovostnega, učinkovitega in po obsegu ustreznega zdravstvenega varstva državljanom na svojem ozemlju.
Furthermore, the transposition of this Directive into national legislation and its application should not result in patients being encouraged to receive treatment outside their Member State of affiliation.
Poleg tega prenos te direktive v nacionalno zakonodajo in njena uporaba ne bi smela spodbujati pacientov, da bi se zdravili izven države članice zdravstvenega zavarovanja.
As recognised by the Council in its Conclusions of 1-2 June 2006 on Common values and principles in European Union Health Systems [4] (hereinafter the ‘Council Conclusions’) there is a set of operating principles that are shared by health systems throughout the Union.
Kot je bilo ugotovljeno v sklepih Sveta z dne 1. in 2. junija 2006 o skupnih vrednotah in načelih zdravstvenih sistemov Evropske unije [4] (v nadaljnjem besedilu: sklepi Sveta), obstaja sklop operativnih načel, ki so skupna zdravstvenim sistemom po vsej Uniji.
Those operating principles are necessary to ensure patients’ trust in cross-border healthcare, which is necessary for achieving patient mobility as well as a high level of health protection.
Ta operativna načela so nujna za zagotavljanje zaupanja pacientov v čezmejno zdravstveno varstvo, ki pa je nujno za doseganje mobilnosti pacientov in visoke ravni varovanja zdravja.
In the same statement, the Council recognised that the practical ways in which these values and principles become a reality vary significantly between Member States.
Vendar je prav tam Svet ugotovil tudi, da se praksa uresničevanja teh vrednot in načel med državami članicami zelo razlikuje.
In particular, decisions about the basket of healthcare to which citizens are entitled and the mechanisms used to finance and deliver that healthcare, such as the extent to which it is appropriate to rely on market mechanisms and competitive pressures to manage health systems, must be taken in the national context.
Zlasti je treba v nacionalni kontekst umestiti odločitve o „košarici“ zdravstvenega varstva, do katere so državljani upravičeni, ter mehanizme, ki se uporabljajo za financiranje in zagotavljanje tega zdravstvenega varstva, kot je na primer obseg, v katerem se je pri upravljanju zdravstvenih sistemov primerno zanesti na tržne mehanizme in konkurenčne pritiske.
As confirmed by the Court of Justice of the European Union (hereinafter the ‘Court of Justice’) on several occasions, while recognising their specific nature, all types of medical care fall within the scope of the TFEU.
Sodišče Evropske unije (v nadaljnjem besedilu: Sodišče) je ob priznavanju njihove posebne narave že večkrat potrdilo, da so v področje uporabe PDEU zajete vse vrste zdravstvene oskrbe.
This Directive respects and is without prejudice to the freedom of each Member State to decide what type of healthcare it considers appropriate.
Ta direktiva spoštuje svobodno izbiro vsake države članice, da se odloči, kakšna je po njenem mnenju primerna oblika zdravstvenega varstva, ter v to odločitev ne posega.
No provision of this Directive should be interpreted in such a way as to undermine the fundamental ethical choices of Member States.
Nobena določba te direktive se ne bi smela razlagati tako, da bi ogrožala temeljne etične odločitve držav članic.
Some issues relating to cross-border healthcare, in particular reimbursement of healthcare provided in a Member State other than that in which the recipient of the care is resident, have already been addressed by the Court of Justice.
Sodišče je že obravnavalo nekatera vprašanja v zvezi s čezmejnim zdravstvenim varstvom, zlasti glede povračila stroškov za zdravstveno varstvo opravljeno v državi članici, ki ni država članica, v kateri ima prejemnik oskrbe stalno prebivališče.
This Directive is intended to achieve a more general, and also effective, application of principles developed by the Court of Justice on a case-by-case basis.
Namen te direktive je doseči bolj splošno in učinkovito uporabo načel, ki jih je Sodišče razvilo na podlagi posameznih primerov.
In the Council Conclusions, the Council recognised the particular value of an initiative on cross-border healthcare ensuring clarity for Union citizens about their rights and entitlements when they move from one Member State to another, in order to ensure legal certainty.
V sklepih Sveta je bil s strani Sveta priznan poseben pomen pobude o čezmejnem zdravstvenem varstvu, ki državljanom Unije zagotavlja jasno razumevanje njihovih pravic in upravičenj, ko se preselijo iz ene države članice v drugo, da se zagotovi pravna varnost.
This Directive aims to establish rules for facilitating access to safe and high-quality cross-border healthcare in the Union and to ensure patient mobility in accordance with the principles established by the Court of Justice and to promote cooperation on healthcare between Member States, whilst fully respecting the responsibilities of the Member States for the definition of social security benefits relating to health and for the organisation and delivery of healthcare and medical care and social security benefits, in particular for sickness.
Cilj te direktive je določiti pravila za zagotavljanje lažjega dostopa do varnega in visokokakovostnega čezmejnega zdravstvenega varstva v Uniji, zagotoviti mobilnost pacientov v skladu z načeli, ki jih je določilo Sodišče, ter spodbuditi sodelovanje med državami članicami na področju zdravstvenega varstva, ob celovitem spoštovanju pristojnosti držav članic pri opredeljevanju dajatev socialne varnosti na področju zdravja ter organizaciji in izvajanju zdravstvenega varstva in zdravstvene oskrbe, pa tudi dajatev socialne varnosti zlasti v primeru bolezni.
This Directive should apply to individual patients who decide to seek healthcare in a Member State other than the Member State of affiliation.
Ta direktiva bi se morala uporabljati za posamezne paciente, ki se odločijo, da bodo zdravstveno varstvo poiskali v drugi državi članici in ne v državi članici zdravstvenega zavarovanja.
As confirmed by the Court of Justice, neither its special nature nor the way in which it is organised or financed removes healthcare from the ambit of the fundamental principle of the freedom to provide services.
Kot je potrdilo Sodišče, posebna narava in način organizacije oziroma financiranja zdravstvenega varstva ne izvzemata iz obsega temeljnega načela svobode opravljanja storitev.
However, the Member State of affiliation may choose to limit the reimbursement of cross-border healthcare for reasons relating to the quality and safety of the healthcare provided, where this can be justified by overriding reasons of general interest relating to public health.
Vendar lahko država članica zdravstvenega zavarovanja povračilo stroškov čezmejnega zdravstvenega varstva omeji iz razlogov, povezanih s kakovostjo in varnostjo opravljenega zdravstvenega varstva, kadar je to mogoče utemeljiti s prevladujočimi razlogi v splošnem interesu javnega zdravja.
The Member State of affiliation may also take further measures on other grounds where this can be justified by such overriding reasons of general interest.
Država članica zdravstvenega zavarovanja lahko sprejme tudi dodatne ukrepe iz drugih razlogov, kadar je to mogoče utemeljiti s takšnimi prevladujočimi razlogi v splošnem interesu.
Indeed, the Court of Justice has laid down that public health protection is among the overriding reasons of general interest that can justify restrictions to the freedom of movement envisaged in the Treaties.
Dejansko je Sodišče določilo, da je varovanje javnega zdravja med prevladujočimi razlogi v splošnem interesu, na podlagi katerih je mogoče upravičiti omejevanje prostega pretoka, določenega s Pogodbama.
The concept of ‘overriding reasons of general interest’ to which reference is made in certain provisions of this Directive has been developed by the Court of Justice in its case-law in relation to Articles 49 and 56 TFEU and may continue to evolve.
Pojem „prevladujočih razlogov v splošnem interesu“, na katerega se sklicujejo nekatere določbe te direktive, je razvilo Sodišče v svoji sodni praksi v zvezi s členoma 49 in 56 PDEU in se lahko razvija še naprej.
The Court of Justice has held on a number of occasions that overriding reasons of general interest are capable of justifying an obstacle to the freedom to provide services such as planning requirements relating to the aim of ensuring sufficient and permanent access to a balanced range of high-quality treatment in the Member State concerned or to the wish to control costs and avoid, as far as possible, any waste of financial, technical and human resources.
Sodišče je večkrat poudarilo, da je s prevladujočimi razlogi v splošnem interesu mogoče utemeljiti ovire za prosto zagotavljanje storitev, kot so zahteve za načrtovanje, in sicer z namenom zagotoviti zadosten in stalen dostop do uravnoteženega obsega visokokakovostne oskrbe v zadevni državi članici, ali z namenom želenega obvladovanja stroškov in, kolikor je mogoče, preprečevanja odvečne porabe finančnih, tehničnih in človeških virov.
The Court of Justice has likewise acknowledged that the objective of maintaining a balanced medical and hospital service open to all may also fall within one of the derogations, on grounds of public health, provided for in Article 52 TFEU, in so far as it contributes to the attainment of a high level of health protection.
Prav tako je Sodišče potrdilo, da lahko tudi cilj vzdrževanja uravnoteženih in vsem dostopnih zdravstvenih in bolnišničnih storitev zaradi razlogov javnega zdravja sodi med odstopanja na podlagi javnega zdravja v skladu s členom 52 PDEU, kolikor prispeva k doseganju visoke ravni varovanja zdravja.
The Court of Justice has also held that such provision of the TFEU permits Member States to restrict the freedom to provide medical and hospital services in so far as the maintenance of treatment capacity or medical competence on national territory is essential for public health.
Sodišče je poleg tega odločilo, da taka določba PDEU državam članicam omogoča, da omejijo svobodo opravljanja zdravstvenih in bolnišničnih storitev, če je ohranitev zmogljivosti zdravljenja ali zdravstvene stroke na nacionalnem ozemlju bistvena za javno zdravje.
It is clear that the obligation to reimburse costs of cross-border healthcare should be limited to healthcare to which the insured person is entitled according to the legislation of the Member State of affiliation.
Jasno je, da bi morala biti obveznost povračila stroškov čezmejnega zdravstvenega varstva omejena na zdravstveno varstvo, do katerega je zavarovana oseba upravičena v skladu z zakonodajo države članice zdravstvenega zavarovanja.
This Directive should not apply to services the primary purpose of which is to support people in need of assistance in carrying out routine, everyday tasks.
Ta direktiva se ne bi smela uporabljati za storitve, katerih glavni namen je pomagati ljudem, ki potrebujejo pomoč pri opravljanju rutinskih vsakodnevnih opravil.
More specifically, this Directive should not apply to those long-term care services deemed necessary in order to enable the person in need of care to live as full and self-determined a life as possible.
Natančneje se ta direktiva ne bi smela uporabljati za tiste storitve dolgotrajne oskrbe, ki veljajo za nujne, da bi oseba, ki potrebuje oskrbo, lahko živela kar najbolj polno in samostojno življenje.
Thus, this Directive should not apply, for example, to long-term care services provided by home care services, in assisted living facilities and in residential homes or housing (‘nursing homes’).
Tako se ta direktiva na primer ne bi smela uporabljati za storitve dolgotrajne oskrbe, ki jih zagotavljajo službe nege in pomoči na domu, v objektih za samostojno življenje ter v domovih za starejše ali domovih za nego („domovi za bolniško nego“).
Given their specificity, access to and the allocation of organs for the purpose of organ transplants should fall outside the scope of this Directive.
Dostop do organov za namene presaditve in dodeljevanje organov v ta namen zaradi njune specifičnosti ne bi smela biti zajeta v področje uporabe te direktive.
For the purpose of reimbursing the costs of cross-border healthcare, this Directive should cover not only the situation where the patient is provided with healthcare in a Member State other than the Member State of affiliation, but also the prescription, dispensation and provision of medicinal products and medical devices where these are provided in the context of a health service.
Za namene povračila stroškov čezmejnega zdravstvenega varstva bi morala ta direktiva poleg primerov, ko je pacientu zagotovljeno zdravstveno varstvo v državi članici, ki ni država članica zdravstvenega zavarovanja, urejati tudi predpisovanje, izdajanje in zagotavljanje zdravil in medicinskih pripomočkov, kadar se zagotavljajo v okviru zdravstvene storitve.
The definition of cross-border healthcare should cover both the situation in which a patient purchases such medicinal products and medical devices in a Member State other than the Member State of affiliation and the situation in which the patient purchases such medicinal products and medical devices in another Member State than that in which the prescription was issued.
Opredelitev čezmejnega zdravstvenega varstva bi morala zajeti tako primere, ko pacient kupi takšna zdravila in medicinske pripomočke v državi članici, ki ni država članica zdravstvenega zavarovanja, kot tudi primere, ko pacient kupi takšna zdravila in medicinske pripomočke v državi članici, ki ni država članica, v kateri je bil izdan recept.
This Directive should not affect Member States’ rules concerning the sale of medicinal products and medical devices over the Internet.
Ta direktiva ne bi smela posegati v pravila držav članic o prodaji zdravil in medicinskih pripomočkov prek spleta.
This Directive should not give any person an entitlement to enter, stay or reside in a Member State in order to receive healthcare in that State.
Ta direktiva ne bi smela nikomur podeljevati pravice do vstopa v državo članico ali začasnega ali stalnega bivanja v njej z namenom, da bi bil deležen zdravstvenega varstva v tej državi.
Where the stay of a person on the territory of a Member State is not in accordance with the legislation of that Member State concerning the right to enter or stay on its territory, such person should not be regarded as an insured person according to the definition in this Directive.
Kadar bivanje osebe na ozemlju države članice ni v skladu z zakonodajo te države članice o pravici do vstopa na njeno ozemlje ali prebivanja na njem, se ta oseba ne bi smela šteti za zavarovano osebo v skladu z opredelitvijo iz te direktive.
Member States should continue to be able to specify in their national legislation who is considered as an insured person for the purposes of their public healthcare scheme and social security legislation as long as the patients’ rights set out in this Directive are secured.
Države članice bi morale biti še naprej pristojne, da v svoji nacionalni zakonodaji določijo, kdo šteje za zavarovano osebo za namene njihovih javnih sistemov zdravstvenega varstva in zakonodaje s področja socialne varnosti, pod pogojem, da so pravice pacientov, določene s to direktivo, zagotovljene.
When a patient receives cross-border healthcare, it is essential for the patient to know in advance which rules will be applicable.
Ko je pacient deležen čezmejnega zdravstvenega varstva, je zanj bistveno, da že vnaprej ve, katera pravila se uporabljajo.
The rules applicable to cross-border healthcare should be those set out in the legislation of the Member State of treatment, given that, in accordance with Article 168(7) TFEU, the organisation and delivery of health services and medical care is the responsibility of the Member States.
Pravila, ki se uporabljajo za čezmejno zdravstveno varstvo, bi morala biti tista, ki jih določa zakonodaja države članice zdravljenja, saj so za organizacijo in izvajanje zdravstvenih storitev in zdravstvene oskrbe v skladu s členom 168(7) PDEU pristojne države članice.
This should help the patient in making an informed choice, and should avoid misapprehension and misunderstanding.
S tem bi lahko pacient lažje sprejel ozaveščeno odločitev, prav tako pa ne bi smelo prihajati do napačnega razumevanja in nesporazumov.
It should also establish a high level of trust between the patient and the healthcare provider.
To bi moralo omogočiti tudi visoko raven zaupanja med pacientom in izvajalcem zdravstvenega varstva.